| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syros Pharmaceuticals, Inc. (SYRS) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. SYRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2020 | Young Richard A | Director | Sell | 5,990 | $11.85 | $70,981.50 | -1.7% | |
| Jul 7, 2020 | Olson Eric R | Chief Scientific Officer | Sell | 1,753 | $11.72 | $20,538.50 | -100% | |
| Jul 1, 2020 | Akkaraju Srinivas81 | Director | Sell | 4,627 | $11.01 | $50,965.94 | -0.3% | |
| Jun 25, 2020 | Akkaraju Srinivas81 | Director | Sell | 154,700 | $11.11 | $1,718,567.77 | -3.3% | |
| Jun 15, 2020 | Young Richard A | Director | Sell | 5,990 | $8.75 | $52,412.50 | -1.6% | |
| May 15, 2020 | Young Richard A | Director | Sell | 5,990 | $9.22 | $55,242.18 | -1.6% | |
| May 13, 2020 | Alles Mark J | Director | Buy | 10,000 | $8.86 | $88,590.00 | New | |
| Apr 15, 2020 | Young Richard A | Director | Sell | 23,960 | $8.75 | $209,650.00 | -6.1% | |
| Feb 18, 2020 | Olson Eric R | Chief Scientific Officer | Sell | 1,446 | $7.38 | $10,674.08 | -100% | |
| Nov 12, 2019 | Springhorn Jeremy P.52 | Chief Business Officer | Buy | 20,000 | $4.98 | $99,595.79 | +50.2% |